Global Anticoagulants Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug Class;

NOACs - Eliquis, Bevyxxa, Xarelto, Savaysa and Pradaxa, Heparins & LMWH, Vitamin K Antagonists and Other Anticoagulant Drugs.

Segmented by Route Of Administration;

Oral Anticoagulants and Injectable Anticoagulants.

Segmented by Application;

Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn137017795 Published Date: April, 2024 Updated Date: May, 2024
Download Free Sample NowDownload Free Sample Now

Introduction

Global Anticoagulants Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 101.3
2021 115.5
2022 131.9
2023 136.9
2024 139.0
2025 154.3
2026 182.5
2027 214.2
2028 248.4
2029 248.7
2030 289.1

In the year 2023, the Global Anticoagulants Market was valued at USD 27,767.65 million. The size of this market is expected to increase to USD 44,705.59 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Route Of Administration
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Anticoagulants Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increase In Prevalence Of Atrial Fibrillation, Venous Thromboembolism And Stroke
        2. Rise in Number Of Geriatric Population
        3. Increase In Prevalence Of Obesity
        4. Surge in healthcare expenditures worldwide
      2. Restraints
        1. High price of NOACs
        2. Poor Demand In Under Developed Countries
      3. Opportunities
        1. Increase In Demand For NOACs
        2. Growth Opportunities In Emerging Markets
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Anticoagulants Market, By Drug Class, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. NOACs
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Eliquis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Bevyxxa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Xarelto
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. Savaysa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. Pradaxa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Heparins & LMWH
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Vitamin K Antagonists
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Other Anticoagulant Drugs
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Anticoagulants Market, By Route Of Administration, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Oral Anticoagulants
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Injectable Anticoagulants
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Anticoagulants Market, By Application, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Atrial Fibrillation & Heart Attack
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Stroke
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Deep Vein Thrombosis (DVT)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Pulmonary Embolism (PE)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Global Anticoagulants Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Aspen Holdings
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Bayer AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Boehringer Ingelheim Pharma GmbH & Co. KG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Bristol-Myers Squibb Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Daiichi Sankyo Co., Ltd.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. GlaxoSmithKline plc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Portola Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Antifibrinolytic Drugs
Global Antifibrinolytic Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antifibrinolytic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Antihyperlipidemic Drugs
Global Antihyperlipidemic Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antihyperlipidemic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Anti-Inflammatory Therapeutic
Global Anti-Inflammatory Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-Inflammatory Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Anti-malarial Drugs
Global Anti-malarial Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-malarial Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...